Vivo Surgical, a pioneering medical gadget firm based mostly in Singapore, has change into the primary start-up to win the celebrated WIPO-IPOS IP for Innovation Award for 2022. Now in its 10th yr, this award celebrates Singaporean corporations which have achieved excellent development by the profitable utility of intangible property and mental property.
Over 40 organizations have obtained this extremely regarded accolade since its inception, with this yr’s standards centered round adaptable and resilient corporations rising by latest world challenges. Vivo Surgical’s merchandise and pipeline comprise modern medical gadgets that improve how surgical procedures are carried out worldwide.
The corporate is presently creating the world’s first disposable robotic for pure orifice transluminal endoscopic surgical procedures (NOTES), and a transportable endoscopic diagnostic gadget – ENLYT™ – with applied sciences that can ultimately be integrated into the robotic’s last design. These options will complement the corporate’s present CE-certified KLARO™ in vivo lighting gadget, which is designed to handle insufficient illumination in working theatres, offering a clearer view of surgical cavities.
The corporate is now working with a number of famend hospitals throughout the US, Europe and Asia, and its gadgets are distributed in a number of worldwide territories.
In simply four-and-a-half years, we now have constructed an organization that focuses on addressing scientific wants with cutting-edge applied sciences. Being acknowledged with this award is a large second, not just for the crew at Vivo Surgical, but in addition for all of the sufferers our merchandise assist around the globe. We hope that this achievement demonstrates how a younger firm like ours can punch above its weight on the world stage, and encourage different start-ups to do the identical.”
Dr Kevin Koh, CEO, Vivo Surgical
